FDA NDC Directory · JSON-LD · Markdown

ziprasidone mesylate

NDC 70518-4755 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerREMEDYREPACK INC.
Marketing categoryAbbreviated NDA (generic) · App ANDA211908
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR
Active ingredientsZIPRASIDONE MESYLATE (20 mg/mL)
Marketing started20260917
Package count1

External sources

Source: openFDA. Public-domain (CC0).